Are you Dr. Huang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 57 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000- Is this information wrong?
Summary
- Dr. Jane Huang, MD is a hematologist in Stanford, California. She is currently licensed to practice medicine in California. She is affiliated with Stanford Health Care and VA Palo Alto Heath Care.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2002 - 2004- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1998 - 2001
University of Washington School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 14 citationsZanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.Peter Hillmen, Barbara Eichhorst, Jennifer R Brown, Nicole Lamanna, Susan M O'Brien, Constantine S Tam, Lugui Qiu, Maciej Kazmierczak, Keshu Zhou, Martin Šimkovič, Jiř...> ;Journal of Clinical Oncology. 2023 Feb 10
- 4 citationsUse of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer.Michael F Gensheimer, Divya Gupta, Manali I Patel, Touran Fardeen, Rachel Hildebrand, Winifred Teuteberg, Briththa Seevaratnam, Mary Khay Asuncion, Nina Alves, Brian R...> ;JCO Oncology Practice. 2023 Feb 1
- 20 citationsZanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke, Syed F Zafar, Jamal Misleh, Edwin C Kingsley, Habte A Yimer, Benjamin Freeman, Subramanya S Rao...> ;The Lancet. Haematology. 2023 Jan 1
- Join now to see all
Press Mentions
BeiGene Presents Updated Safety and Efficacy Findings on BRUKINSA (Zanubrutinib) in BTK Inhibitor-Intolerant Patients with Relapsed or Refractory B-cell MalignanciesDecember 11th, 2021- BeiGene to Present Clinical Data on BRUKINSA in Chronic Lymphocytic Leukemia at the 63rd ASH Annual MeetingNovember 4th, 2021
- ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa Fleshes Out Competitive Leukemia Data AgainNovember 4th, 2021
- Join now to see all
Hospital Affiliations
VA Palo Alto Heath CarePalo Alto, California
Stanford Health CarePalo Alto, California
